Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in Melanoma.

Saved in:
Bibliographic Details
Title: Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in Melanoma.
Authors: Quacoe AE; Department of Dermatology, University Hospital Zurich and Medical Faculty, University of Zurich, 8058 Zurich, Switzerland., Freiberger SN; Institute of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland., Levesque MP; Department of Dermatology, University Hospital Zurich and Medical Faculty, University of Zurich, 8058 Zurich, Switzerland., Dummer R; Department of Dermatology, University Hospital Zurich and Medical Faculty, University of Zurich, 8058 Zurich, Switzerland., Ramelyte E; Department of Dermatology, University Hospital Zurich and Medical Faculty, University of Zurich, 8058 Zurich, Switzerland.
Source: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2026 Mar 10; Vol. 62 (3). Date of Electronic Publication: 2026 Mar 10.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet ISSN: 1648-9144 (Electronic) Linking ISSN: 1010660X NLM ISO Abbreviation: Medicina (Kaunas) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1648-9144
DOI:10.3390/medicina62030510